TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/6/23 16:55 | 1/6/23 | CCCC | C4 Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Anderson Kenneth Carl | MA | D | M.d | 3 | 3.90 | 0 | 1 | 0 | 299 | D | |||||||||||||||
10/4/22 18:05 | 10/3/22 | CCCC | C4 Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Anderson Kenneth Carl | MA | D | M.d | 3 | 3.90 | 0 | 1 | 0 | 297 | D | |||||||||||||||
7/18/22 17:18 | 7/15/22 | CCCC | C4 Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Anderson Kenneth Carl | MA | D | M.d | 6 | 3.90 | 0 | 1 | 0 | 295 | D | |||||||||||||||
1/26/22 17:26 | 1/26/22 | CCCC | C4 Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Anderson Kenneth Carl | MA | D | M.d | 8 | 3.90 | 0 | 2 | 1 | 292 | D | |||||||||||||||
4/14/21 16:39 | 4/14/21 | CCCC | C4 Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Anderson Kenneth Carl | MA | D | M.d | 3 | 3.90 | 0 | 1 | 0 | 289 | M | |||||||||||||||
1/26/21 16:34 | 1/22/21 | CCCC | C4 Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Anderson Kenneth Carl | MA | D | M.d | 6 | 3.76 | 0 | 2 | 1 | 288 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |